-
I do. The platform should be proposed to your lab, depending on your assay throughput, in the $50k for both instruments (you can't do with only one!) and cost per assay should be in between $25-$40/assay. The F2+F5 multiplex assay is supposed to be this cost too. To my opinion: reasonably priced. Fact is, you need your own DNA extraction automated platform to have the complete system. Until Verigene 2 arrives. -
Does anyone have experience with Nanosphere's Verigene system?
We're looking into it and I was hoping someone has some personal hands-on experience they could share.
Since I haven't been able to contact someone, if you could share the approximate price of the Processor and Reader, that would be great, too.
Website
Verigene system
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Leave a comment: